ZTS / Zoetis Inc. - Pemfailan SEC, Laporan Tahunan, Penyata Proksi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 27, 2025 Zoetis Inc. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 27, 2025 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction of incorporation) (Commission File Number

U.S. $1,250,000,000 REVOLVING CREDIT AGREEMENT dated as of August 27, 2025, ZOETIS INC., THE LENDERS NAMED HEREIN THE ISSUING BANKS NAMED HEREIN JPMORGAN CHASE BANK, N.A., as Administrative Agent BANK OF AMERICA, N.A., BARCLAYS BANK PLC, CITIBANK, N.

EX-10.1 Exhibit 10.1 U.S. $1,250,000,000 REVOLVING CREDIT AGREEMENT dated as of August 27, 2025, among ZOETIS INC., THE LENDERS NAMED HEREIN THE ISSUING BANKS NAMED HEREIN and JPMORGAN CHASE BANK, N.A., as Administrative Agent BANK OF AMERICA, N.A., BARCLAYS BANK PLC, CITIBANK, N.A. and MUFG BANK, LTD., as Syndication Agents BANK OF AMERICA, N.A., BARCLAYS BANK PLC, CITIBANK, N.A. and MUFG BANK, L

ZOETIS INC. 5.000% SENIOR NOTES DUE 2035 PRINCIPAL AMOUNT No. 1 $[•]

EX-4.4 Exhibit 4.4 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 11, 2025 Zoetis Inc. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 11, 2025 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction of incorporation) (Commission File Number

Zoetis Inc. $850,000,000 4.150% Senior Notes due 2028 $1,000,000,000 5.000% Senior Notes due 2035 Underwriting Agreement

EX-1.1 Exhibit 1.1 Zoetis Inc. $850,000,000 4.150% Senior Notes due 2028 $1,000,000,000 5.000% Senior Notes due 2035 Underwriting Agreement August 11, 2025 Barclays Capital Inc. BofA Securities, Inc. Citigroup Global Markets Inc. J.P. Morgan Securities LLC MUFG Securities Americas Inc. As Representatives of the several Underwriters listed in Schedule 1 hereto c/o Barclays Capital Inc. 745 Seventh

ZOETIS INC. 4.150% SENIOR NOTES DUE 2028

EX-4.3 Exhibit 4.3 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE

ZOETIS INC. SEVENTH SUPPLEMENTAL INDENTURE Dated as of August 18, 2025 4.150% Senior Notes due 2028 5.000% Senior Notes due 2035 (Seventh Supplemental Indenture to the Indenture Dated as of January 28, 2013) DEUTSCHE BANK TRUST COMPANY AMERICAS, as T

EX-4.2 Exhibit 4.2 ZOETIS INC. SEVENTH SUPPLEMENTAL INDENTURE Dated as of August 18, 2025 4.150% Senior Notes due 2028 5.000% Senior Notes due 2035 (Seventh Supplemental Indenture to the Indenture Dated as of January 28, 2013) DEUTSCHE BANK TRUST COMPANY AMERICAS, as Trustee TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 2 Section 1.01 Certain Terms Defined in the Indenture; Additional Terms 2 Secti

$1,850,000,000 Zoetis Inc. $850,000,000 4.150% SENIOR NOTES DUE 2028 $1,000,000,000 5.000% SENIOR NOTES DUE 2035

424B3 Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-289241 PROSPECTUS SUPPLEMENT (To Prospectus dated August 5, 2025) $1,850,000,000 Zoetis Inc. $850,000,000 4.150% SENIOR NOTES DUE 2028 $1,000,000,000 5.000% SENIOR NOTES DUE 2035 The 4.150% senior notes due 2028 (the “2028 notes”) will mature on August 17, 2028 and the 5.000% senior notes due 2035 (the “2035 notes”) will

Security Type

Calculation of Filing Fee Tables S-3 Zoetis Inc. Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward Initial Effecti

Pricing Term Sheet Zoetis Inc. August 11, 2025 $850,000,000 4.150% Senior Notes due 2028 $1,000,000,000 5.000% Senior Notes due 2035 Issuer: Zoetis Inc. Principal Amount: $850,000,000 $1,000,000,000 Maturity Date: August 17, 2028 August 17, 2035 Inte

FWP Issuer Free Writing Prospectus Filed Pursuant to Rule 433 Registration Statement No.

Subject to Completion, Dated August 11, 2025

424B3 Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-289241 The information contained in this preliminary prospectus supplement is not complete and may be changed. A registration statement relating to these securities is effective. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and are not soliciting an offe

Zoetis Announces Second Quarter 2025 Results, Raises Full Year 2025 Outlook

EXHIBIT 99.1 Zoetis Announces Second Quarter 2025 Results, Raises Full Year 2025 Outlook •Reports Revenue of $2.5 Billion, Growing 4%, and Net Income of $718 Million, or $1.61 per Diluted Share, Increasing 15% and 18%, Respectively, on a Reported Basis for Second Quarter 2025 •Delivers 8% Organic Operational Growth in Revenue and 10% Organic Operational Growth in Adjusted Net Income for Second Qua

Statement of Eligibility and Qualification on Form T-1 under the Trust Indenture Act of 1939, as amended

EX-25.1 Exhibit 25.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ☐ CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) DEUTSCHE BANK TRUST COMPANY AMERICAS (formerly BANKERS TRUST COMPANY) (Exact name of trustee as

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 00

As filed with the Securities and Exchange Commission on August 5, 2025

S-3ASR Table of Contents As filed with the Securities and Exchange Commission on August 5, 2025 Registration No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 5, 2025 Zoetis Inc. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 5, 2025 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incor

Filing Fee Exhibit

EXHIBIT 107 Calculation of Filing Fee Table FORM S-3 (Form Type) ZOETIS INC. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum  Offering Price Per Unit Maximum  Aggregate Offering Price Fee Rate  Amount of Registration  Fee Carry Fo

Exhibit 10.1

Exhibit 10.1 ZOETIS EXECUTIVE SEVERANCE PLAN INTRODUCTION The purpose of the Zoetis Executive Severance Plan (the “Plan”) is to provide severance benefits to certain executives of Zoetis Inc. and its subsidiaries and affiliates (collectively, the “Company”), in each case, selected for participation in the Plan by the Plan Administrator, whose employment is involuntarily terminated. The Plan is des

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No: 001-35797 A. Full titl

Conflict Minerals Report for Zoetis Inc. For the Year Ended December 31, 2024

Exhibit 1.01 Conflict Minerals Report for Zoetis Inc. For the Year Ended December 31, 2024 Introduction This Conflict Minerals Report (the “Report”) has been prepared by Zoetis Inc. (“Zoetis,” the “Company,” “we,” “us,” or “our”) as provided for in Rule 13p-1 under the Securities Exchange Act of 1934, as amended, and Form SD (collectively, the “Conflict Minerals Rule”), for the reporting period fr

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission Fi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File Number) (I.R.S. Employer Identification No.) of incorporation or organization) 10 Sylvan Way, Parsippany, NJ 07054 (Address of principal executive

Dr. Mark Stetter Elected to Zoetis Board of Directors Dean of the University of California, Davis School of Veterinary Medicine brings extensive and valuable experience in animal health to Zoetis Board

Exhibit 99.1 Media Contacts: Investor Contacts: Jennifer Albano Steve Frank 1-862-399-0810 (o) 1-973-822-7141 (o) [email protected] [email protected] Laura Panza Nick Soonthornchai 1-973-975-5176 (o) 1-973-443-2792 (o) [email protected] [email protected] Dr. Mark Stetter Elected to Zoetis Board of Directors Dean of the University of California, Davis School of Veteri

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 21, 2025 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incorpo

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 21, 2025 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incorpo

Zoetis Declares Third Quarter 2025 Dividend

EXHIBIT 99.1 Media Contacts: Investor Contacts: Jennifer Albano Steve Frank 1-862-399-0810 (o) 1-973-822-7141 (o) [email protected] [email protected] Laura Panza Nick Soonthornchai 1-973-975-5176 (o) 1-973-443-2792 (o) [email protected] [email protected] Zoetis Declares Third Quarter 2025 Dividend PARSIPPANY, N.J. – May 21, 2025 –The Board of Directors of Zoetis Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0

Zoetis Announces First Quarter 2025 Results

EXHIBIT 99.1 Zoetis Announces First Quarter 2025 Results •Reports Revenue of $2.2 Billion, Growing 1%, and Net Income of $631 Million, or $1.41 per Diluted Share, Increasing 5% and 8%, Respectively, on a Reported Basis for First Quarter 2025 •Delivers 9% Organic Operational Growth in Revenue and 6% Organic Operational Growth in Adjusted Net Income for First Quarter 2025 •Reports Adjusted Net Incom

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 6, 2025 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incorpor

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Q Filed by a party other than the Registrant £ Check the appropriate box: £ Preliminary Proxy Statement £ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) £ Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ý Defin

Exhibit 4.19

Exhibit 4.19 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Zoetis Inc. (“Zoetis,” the “Company,” “we,” “us” and “our”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): our common stock, par value $0.01 per share. Description of Common Stock The follo

Exhibit 10.41

Exhibit 10.41 ZOETIS INC. 2013 EQUITY AND INCENTIVE PLAN PERFORMANCE RESTRICTED STOCK UNIT AWARD (RELATIVE TSR) Zoetis Inc. (the “Company”) has granted to the person named below (the “Participant”), an Award of Performance Restricted Stock Units under Section 9.1 and Article V of the Zoetis Inc. 2013 Equity and Incentive Plan, as amended and restated (the “Plan”). This Award is subject to all of t

Exhibit 19

Exhibit 19 ZOETIS INC. INSIDER TRADING AND PROTECTION OF MATERIAL NONPUBLIC INFORMATION POLICY 1.Purpose and Scope. This Zoetis Inc. (“Zoetis”, the “Company,” “us”, “our”, or “we”) Insider Trading and Protection of Material Nonpublic Information Policy (the “Policy”) provides all directors, officers, colleagues and contingent workers1 of Zoetis and its subsidiaries (together, the “Covered Persons”

Exhibit 21.1

Exhibit 21.1 SUBSIDIARIES OF THE COMPANY The following is a list of subsidiaries of the company as of December 31, 2024, omitting some subsidiaries which, considered in the aggregate, would not constitute a significant subsidiary. SUBSIDIARY NAME JURISDICTION OF INCORPORATION / FORMATION Abaxis Europe GmbH Germany Abaxis, Inc. United States Adivo GmbH Germany Alpharma (Bermuda), LLC United States

Exhibit 10.42

Exhibit 10.42 2013 Equity and Incentive Plan, as amended and restated as of May 19, 2022 Sub-Plan for UK Employees The terms set forth herein shall apply to Awards offered to Employees who are resident in the United Kingdom (“UK Employees”). All capitalized terms used herein but not otherwise defined shall have the respective meanings set forth in the Plan. The rules of the Plan shall apply to all

Exhibit 10.39

Exhibit 10.39 ZOETIS INC. 2013 EQUITY AND INCENTIVE PLAN PERFORMANCE RESTRICTED STOCK UNIT AWARD (REVENUE) Zoetis Inc. (the “Company”) has granted to the person named below (the “Participant”), an Award of Performance Restricted Stock Units under Section 9.1 and Article V of the Zoetis Inc. 2013 Equity and Incentive Plan, as amended and restated (the “Plan”). This Award is subject to all of the te

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 13, 2025 Zoetis Inc. (Ex

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 13, 2025 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of in

Zoetis Reports Fourth Quarter and Full Year 2024 Results

EXHIBIT 99.1 Zoetis Reports Fourth Quarter and Full Year 2024 Results •Reports Revenue of $2.3 Billion, Growing 5%, and Net Income of $581 Million, or $1.29 per Diluted Share, Increasing 11% and 13%, Respectively, on a Reported Basis for Fourth Quarter 2024 ◦Delivers 6% Operational Growth in Revenue and 9% Operational Growth in Adjusted Net Income for Fourth Quarter 2024 ◦Delivers 9% Organic Opera

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35

Zoetis Declares Second Quarter 2025 Dividend

EXHIBIT 99.1 Media Contacts: Investor Contacts: Jennifer Albano Steve Frank 1-973-945-4333 (o) 1-973-822-7141 (o) [email protected] [email protected] Laura Panza Nick Soonthornchai 1-973-975-5176 (o) 1-973-443-2792 (o) [email protected] [email protected] Zoetis Declares Second Quarter 2025 Dividend PARSIPPANY, N.J. – February 6, 2025 –The Board of Directors of Zoetis

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 6, 2025 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of inc

43rd Annual J.P. Morgan Healthcare Conference January 14, 2025 A Best in Breed Growth Strategy 2 Forward-Looking Statements This presentation contains forward-looking statements, which reflect the current views of Zoetis with respect to: business pla

43rd Annual J.P. Morgan Healthcare Conference January 14, 2025 A Best in Breed Growth Strategy 2 Forward-Looking Statements This presentation contains forward-looking statements, which reflect the current views of Zoetis with respect to: business plans or prospects, future operating or financial performance; future guidance, future operating models, R&D costs; timing and likelihood of success; exp

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 13, 2025 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of inc

Zoetis Declares First Quarter 2025 Dividend; Board Approves 16% Payment Increase

EXHIBIT 99.1 Media Contacts: Investor Contacts: Jennifer Albano Steve Frank 1-973-945-4333 (o) 1-973-822-7141 (o) [email protected] [email protected] Laura Panza Nick Soonthornchai 1-973-975-5176 (o) 1-973-443-2792 (o) [email protected] [email protected] Zoetis Declares First Quarter 2025 Dividend; Board Approves 16% Payment Increase PARSIPPANY, N.J. – December 12, 2

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 12, 2024 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of in

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 11, 2024 Zoetis Inc. (Ex

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 11, 2024 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of in

ZOETIS APPOINTS JAMIE BRANNAN TO NEWLY CREATED CHIEF COMMERICAL OFFICER ROLE New Commercial Organizational Structure to Accelerate Long-Term Growth Strategy in Key Markets and Optimize Global Commercial Operations

EXHIBIT 99.1 Media Contacts: Investor Contacts: Jennifer Albano Steve Frank 1-862-399-0810 (o) 1-973-822-7141 (o) [email protected] [email protected] Laura Panza Nick Soonthornchai 1-973-975-5176 (o) 1-973-443-2792 (o) [email protected] [email protected] ZOETIS APPOINTS JAMIE BRANNAN TO NEWLY CREATED CHIEF COMMERICAL OFFICER ROLE New Commercial Organizational Structu

Zoetis Announces Third Quarter 2024 Results

EXHIBIT 99.1 Zoetis Announces Third Quarter 2024 Results •Reports Revenue of $2.4 Billion, Growing 11%, and Net Income of $682 Million, or $1.50 per Diluted Share, Increasing 14% and 16%, Respectively, on a Reported Basis for Third Quarter 2024 •Delivers 14% Operational Growth in Revenue and 15% Operational Growth in Adjusted Net Income for Third Quarter 2024 •Reports Adjusted Net Income of $716 M

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 4, 2024 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of inc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe

Zoetis Declares Fourth Quarter 2024 Dividend

EXHIBIT 99.1 Media Contacts: Investor Contacts: Jennifer Albano Steve Frank 1- 862-399-0810 (o) 1-973-822-7141 (o) [email protected] [email protected] Laura Panza Nick Soonthornchai 1-973-975-5176 (o) 1-973-443-2792 (o) [email protected] [email protected] Zoetis Declares Fourth Quarter 2024 Dividend PARSIPPANY, N.J. – October 10, 2024 –The Board of Directors of Zoeti

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 10, 2024 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of inc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 00

Zoetis Announces Second Quarter 2024 Results

EXHIBIT 99.1 Zoetis Announces Second Quarter 2024 Results •Reports Revenue of $2.4 Billion, Growing 8%, and Net Income of $624 Million, or $1.37 per Diluted Share, Decreasing 7% and 6%, Respectively, on a Reported Basis for Second Quarter 2024 •Delivers 11% Operational Growth in Revenue and 18% Operational Growth in Adjusted Net Income for Second Quarter 2024 •Reports Adjusted Net Income of $711 M

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 6, 2024 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incor

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 1, 2024 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incor

Zoetis Announces Authorization of Multi-Year $6 Billion Share Repurchase Program

Exhibit 99.1 Media Contacts: Investor Contacts: Jennifer Albano Steve Frank 1-862-399-0810 (o) 1-973-822-7141 (o) [email protected] [email protected] Laura Panza Nick Soonthornchai 1-973-975-5176 (o) 1-973-443-2792 (o) [email protected] [email protected] Zoetis Announces Authorization of Multi-Year $6 Billion Share Repurchase Program PARSIPPANY, N.J. – August 1, 2024

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K (Mark One) ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No: 001-35797 A. Full title of

Conflict Minerals Report for Zoetis Inc. For the Year Ended December 31, 2023

Exhibit 1.01 Conflict Minerals Report for Zoetis Inc. For the Year Ended December 31, 2023 Introduction This Conflict Minerals Report (the “Report”) has been prepared by Zoetis Inc. (“Zoetis,” the “Company,” “we,” “us,” or “our”) as provided for in Rule 13p-1 under the Securities Exchange Act of 1934, as amended, and Form SD (collectively, the “Conflict Minerals Rule”), for the reporting period fr

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 (State or Other Jurisdiction (Commission File Number)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 (State or Other Jurisdiction (Commission File Number) of Incorporation) 10 Sylvan Way Parsippany, NJ 07054 (Address of principal executive office) (Zip code) Roxanne Lagano Executive Vice President, Gener

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 20, 2024 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incorpo

Exhibit 10.40

Exhibit 10.1 10 Sylvan Way Parsippany, NJ 07054 April 16, 2024 (revised as of May 20, 2024) Ms. Heidi Chen Re: Separation from Service Dear Heidi: On behalf of Zoetis Inc. (the “Company”) and its Board of Directors, I want to thank you for your years of service to the Company, during which you have made many meaningful contributions. This letter agreement (this “Letter Agreement”) sets forth the t

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 21, 2024 Zoetis Inc. (Exact n

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 21, 2024 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incorpo

Exhibit 3.1

Exhibit 3.1 RESTATED CERTIFICATE OF INCORPORATION OF ZOETIS INC. Zoetis Inc. (the “Corporation”), a corporation organized and existing under the General Corporation Law of the State of Delaware (the “GCL”), does hereby certify as follows: 1. The name of the Corporation is Zoetis Inc. The Corporation was originally incorporated under the name Zoetis Inc., pursuant to the original Certificate of Inc

Zoetis Declares Third Quarter 2024 Dividend

EXHIBIT 99.1 Media Contacts: Investor Contacts: Jenielle Alonso Steve Frank 1-973-945-4333 (o) 1-973-822-7141 (o) [email protected] [email protected] Laura Panza Nick Soonthornchai 1-973-975-5176 (o) 1-973-443-2792 (o) [email protected] [email protected] Zoetis Declares Third Quarter 2024 Dividend PARSIPPANY, N.J. – May 22, 2024 –The Board of Directors of Zoetis Inc.

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 22, 2024 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incorpo

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ¨ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

SUPPLEMENT TO PROXY STATEMENT ANNUAL MEETING OF SHAREHOLDERS MAY 22, 2024

SUPPLEMENT TO PROXY STATEMENT ANNUAL MEETING OF SHAREHOLDERS MAY 22, 2024 May 6, 2024 Dear Fellow Shareholders: In advance of our 2024 Annual Meeting of Shareholders scheduled for May 22, 2024 (the “2024 Annual Meeting”), I am writing to you on behalf of the Board of Directors (the “Board”) of Zoetis Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 2, 2024 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incorpor

Zoetis Announces First Quarter 2024 Results

EXHIBIT 99.1 Zoetis Announces First Quarter 2024 Results •Reports Revenue of $2.2 Billion, Growing 10%, and Net Income of $599 Million, or $1.31 per Diluted Share, Increasing 9% and 10%, Respectively, on a Reported Basis for First Quarter 2024 •Delivers 12% Operational Growth in Revenue and 15% Operational Growth in Adjusted Net Income for First Quarter 2024 •Reports Adjusted Net Income of $634 Mi

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 16, 2024 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incor

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.     )

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.     ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rul

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ¨ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

Zoetis Appoints Gavin D.K. Hattersley to its Board of Directors Molson Coors’ President and Chief Executive Officer brings valuable business leadership and global public company experience to Zoetis Board

Exhibit 99.1 Media Contacts: Investor Contacts: Jenielle Alonso Steve Frank 1-973-945-4333 (o) 1-973-822-7141 (o) [email protected] [email protected] Laura Panza Nick Soonthornchai 1-973-975-5176 (o) 1-973-443-2792 (o) [email protected] [email protected] Zoetis Appoints Gavin D.K. Hattersley to its Board of Directors Molson Coors’ President and Chief Executive Office

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 1, 2024 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incorp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.     )

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.     ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rul

Exhibit 97

Exhibit 97 ZOETIS INC. COMPENSATION RECOVERY POLICY 1.Purpose. This Policy sets forth the terms on which the Company may recover erroneously awarded compensation to its executive officers. This Policy is intended to comply with Section 10D of the Exchange Act and Section 303A.14 of the NYSE Listed Company Manual. 2.Definitions. Unless the context otherwise requires, the following terms used in thi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35

Exhibit 21.1

Exhibit 21.1 SUBSIDIARIES OF THE COMPANY The following is a list of subsidiaries of the company as of December 31, 2023, omitting some subsidiaries which, considered in the aggregate, would not constitute a significant subsidiary. SUBSIDIARY NAME JURISDICTION OF INCORPORATION / FORMATION Abaxis Europe GmbH Germany Abaxis, Inc. United States Adivo GmbH Germany Alpharma (Bermuda), LLC United States

ZTS / Zoetis Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* Name of issuer: Zoetis, Inc. Class A Title of Class of Securities: Common Stock CUSIP Number: 98978V103 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Zoetis Reports Fourth Quarter and Full Year 2023 Results

EXHIBIT 99.1 Zoetis Reports Fourth Quarter and Full Year 2023 Results •For Fourth Quarter 2023, Zoetis Reports Revenue of $2.2 Billion, Growing 8%, and Net Income of $525 Million, or $1.14 per Diluted Share, Increasing 14% and 15%, Respectively, on a Reported Basis ◦Delivers 8% Operational Growth in Revenue and 6% Operational Growth in Adjusted Net Income for Fourth Quarter 2023 ◦Reports Adjusted

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 13, 2024 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of in

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 6, 2024 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of inc

Zoetis Declares Second Quarter 2024 Dividend

EXHIBIT 99.1 Media Contacts: Investor Contacts: Jenielle Alonso Steve Frank 1-973-945-9333 (o) 1-973-822-7141 (o) [email protected] [email protected] Laura Panza Nick Soonthornchai 1-973-975-5176 (o) 1-973-443-2792 (o) [email protected] [email protected] Zoetis Declares Second Quarter 2024 Dividend PARSIPPANY, N.J. – February 6, 2024 –The Board of Directors of Zoetis

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 7, 2023 Zoetis Inc. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 7, 2023 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of inc

Zoetis Declares First Quarter 2024 Dividend; Board Approves 15% Payment Increase

EXHIBIT 99.1 Media Contacts: Investor Contacts: Bill Price Steve Frank 1-973-443-2742 (o) 1-973-822-7141 (o) [email protected] [email protected] Laura Panza Nick Soonthornchai 1-973-975-5176 (o) 1-973-443-2792 (o) [email protected] [email protected] Zoetis Declares First Quarter 2024 Dividend; Board Approves 15% Payment Increase PARSIPPANY, N.J. – December 7, 2023 –The

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 2, 2023 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of inc

Zoetis Announces Third Quarter 2023 Results

EXHIBIT 99.1 Zoetis Announces Third Quarter 2023 Results •Reports Revenue of $2.2 Billion, Growing 7%, and Net Income of $596 Million, or $1.29 per Diluted Share, Increasing 13% and 14%, Respectively, on a Reported Basis for Third Quarter 2023 •Delivers 8% Operational Growth in Revenue and a 13% Operational Growth in Adjusted Net Income for Third Quarter 2023 •Reports Adjusted Net Income of $629 M

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 12, 2023 Zoetis Inc. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 12, 2023 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of inc

Zoetis Declares Fourth Quarter 2023 Dividend

EXHIBIT 99.1 Media Contacts: Investor Contacts: Bill Price Steve Frank 1-973-443-2742 (o) 1-973-822-7141 (o) [email protected] [email protected] Laura Panza Nick Soonthornchai 1-973-975-5176 (c) 1-973-443-2792 (o) [email protected] [email protected] Zoetis Declares Fourth Quarter 2023 Dividend PARSIPPANY, N.J. – October 12, 2023 –The Board of Directors of Zoetis Inc. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 00

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 8, 2023 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incor

Zoetis Announces Second Quarter 2023 Results

EXHIBIT 99.1 Zoetis Announces Second Quarter 2023 Results •Reports Revenue of $2.2 Billion, Growing 6%, and Net Income of $671 Million, or $1.45 per Diluted Share, Increasing 27% and 29%, Respectively, on a Reported Basis for Second Quarter 2023 •Delivers 9% Operational Growth in Revenue and a 12% Operational Growth in Adjusted Net Income for Second Quarter 2023 •Reports Adjusted Net Income of $65

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K (Mark One) ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No: 001-35797 A. Full title of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 (State or Other Jurisdiction (Commission File Number)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 (State or Other Jurisdiction (Commission File Number) of Incorporation) 10 Sylvan Way Parsippany, NJ 07054 (Address of principal executive office) (Zip code) Heidi C. Chen Executive Vice President, Genera

Conflict Minerals Report for Zoetis Inc. For the Year Ended December 31, 2022

Exhibit 1.01 Conflict Minerals Report for Zoetis Inc. For the Year Ended December 31, 2022 Introduction This Conflict Minerals Report (the “Report”) has been prepared by Zoetis Inc. (“Zoetis,” the “Company,” “we,” “us,” or “our”) as provided for in Rule 13p-1 under the Securities Exchange Act of 1934, as amended, and Form SD (collectively, the “Conflict Minerals Rule”), for the reporting period fr

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 25, 2023 Zoetis Inc. (Exact n

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 25, 2023 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incorpo

Shaping Animal Health for the Next Decade Zoetis Investor Day May 25, 2023 Exhibit 99.2 Introduction Steve Frank Vice President, Investor Relations Forward-Looking Statements This presentation contains forward-looking statements, which reflect the cu

zoetisinvestorday2023pr Shaping Animal Health for the Next Decade Zoetis Investor Day May 25, 2023 Exhibit 99.

Zoetis Holds Investor Day and Presents Strategy to Shape Animal Health for the Next Decade

EXHIBIT 99.1 Zoetis Holds Investor Day and Presents Strategy to Shape Animal Health for the Next Decade PARSIPPANY, N.J. – May 25, 2023 – Zoetis Inc. (NYSE:ZTS) is hosting an investor day at 9:00 a.m. ET today at the New York Stock Exchange, where the company will dive into its compelling growth ambitions, its innovative and robust R&D pipeline and its financial roadmap to continue delivering shar

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 18, 2023 Zoetis Inc. (Exact n

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 18, 2023 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incorpo

Exhibit 3.1

Exhibit 3.1 RESTATED CERTIFICATE OF INCORPORATION OF ZOETIS INC. Zoetis Inc. (the “Corporation”), a corporation organized and existing under the General Corporation Law of the State of Delaware (the “GCL”), does hereby certify as follows: 1. The name of the Corporation is Zoetis Inc. The Corporation was originally incorporated under the name Zoetis Inc., pursuant to the original Certificate of Inc

Exhibit 3.2

Exhibit 3.2 AMENDED AND RESTATED BY-LAWS OF ZOETIS INC. (Amended and Restated as of May 18, 2023) Article I Stockholders’ Meetings. 1. Place of Meetings. Meetings of the stockholders shall be held at such time and place, if any, within or without the State of Delaware as may be designated by the Board of Directors. 2. Annual Meetings. The annual meeting of the stockholders shall be held on such da

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 11, 2023 Zoetis Inc. (Exact n

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 11, 2023 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incorpo

Zoetis Declares Third Quarter 2023 Dividend

EXHIBIT 99.1 Media Contacts: Investor Contacts: Bill Price Steve Frank 1-973-443-2742 (o) 1-973-822-7141 (o) [email protected] [email protected] Kristen Seely Nick Soonthornchai 1-973-443-2777 (o) 1-973-443-2792 (o) [email protected] [email protected] Zoetis Declares Third Quarter 2023 Dividend PARSIPPANY, N.J. – May 11, 2023 –The Board of Directors of Zoetis Inc. (N

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0

Exhibit 10.38

Exhibit 10.2 ZOETIS INC. 2013 EQUITY AND INCENTIVE PLAN CASH RESTRICTED STOCK UNIT AWARD Zoetis Inc. (the “Company”) has granted to the person named below (the “Participant”), a cash restricted stock unit award (“Cash RSU Award”), subject to all of the terms, definitions and provisions of this Cash RSU Award and the Zoetis Inc. 2013 Equity and Incentive Plan, as amended and restated (the “Plan”),

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 4, 2023 Zoetis Inc. (Exact na

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 4, 2023 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incorpor

Zoetis Announces First Quarter 2023 Results

EXHIBIT 99.1 Zoetis Announces First Quarter 2023 Results •Reports Revenue of $2.0 Billion, Growing 1%, and Net Income of $552 Million, or $1.19 per Diluted Share, Decreasing 7% and 6%, Respectively, on a Reported Basis for First Quarter 2023 •Delivers 4% Operational Growth in Revenue and a 3% Operational Decline in Adjusted Net Income for First Quarter 2023 •Reports Adjusted Net Income of $607 Mil

Exhibit 10.37

Exhibit 10.1 ZOETIS INC. 2013 EQUITY AND INCENTIVE PLAN DIRECTOR RESTRICTED STOCK UNIT AWARD Zoetis Inc. (the “Company”) has granted to the person named below (the “Participant”), an Award of Restricted Stock Units under Section 8.1 of the Zoetis Inc. 2013 Equity and Incentive Plan, as amended and restated (the “Plan”). This Award is subject to all of the terms, definitions and provisions of this

Zoetis Inc. (ZTS)

Zoetis Inc. (ZTS) Shareholder Alert Voluntary submission by John Chevedden, POB 2673, Redondo Beach, CA 90278 Zoetis Shareholder since 2019 Beware of this misleading Zoetis Board statement in regard to Proposal 5: A threshold of 25% or higher has been adopted by approximately 52% of S&P 500 companies. Because per Zoetis Proposal 4, Zoetis shareholders will first have to sign up perhaps 40% of Zoet

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.     )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.     ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ D

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.     )

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.     ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rul

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.     )

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.     ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rul

Exhibit 10.3

Exhibit 10.36 ZOETIS INC. 2013 EQUITY AND INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD Zoetis Inc. (the “Company”) has granted to the person named below (the “Participant”), an Award of Restricted Stock Units under Section 8.1 of the Zoetis Inc. 2013 Equity and Incentive Plan, as amended and restated (the “Plan”). This Award is subject to all of the terms, definitions and provisions of this Restrict

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 14, 2023 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of in

Exhibit 10.3

Exhibit 10.37 ZOETIS INC. 2013 EQUITY AND INCENTIVE PLAN STOCK OPTION AWARD Zoetis Inc. (the “Company”) has granted to the person named below (the “Participant”), a Non-Qualified Stock Option (the “Option”) to purchase the number of Shares of Company common stock (the “Shares”) set forth below at the exercise price per Share set forth below (the “Exercise Price”). This Option is granted under Arti

Exhibit 10.3

Exhibit 10.38 ZOETIS INC. 2013 EQUITY AND INCENTIVE PLAN PERFORMANCE RESTRICTED STOCK UNIT AWARD Zoetis Inc. (the “Company”) has granted to the person named below (the “Participant”), an Award of Performance Restricted Stock Units under Section 9.1 and Article V of the Zoetis Inc. 2013 Equity and Incentive Plan, as amended and restated (the “Plan”). This Award is subject to all of the terms, defin

Exhibit 4.

Exhibit 4.20 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Zoetis Inc. (“Zoetis,” the “Company,” “we,” “us” and “our”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): our common stock, par value $0.01 per share. Description of Common Stock The follo

Exhibit 21.1

Exhibit 21.1 SUBSIDIARIES OF THE COMPANY The following is a list of subsidiaries of the company as of December 31, 2022, omitting some subsidiaries which, considered in the aggregate, would not constitute a significant subsidiary. SUBSIDIARY NAME JURISDICTION OF INCORPORATION / FORMATION Abaxis Asia Limited Hong Kong Abaxis Europe GmbH Germany Abaxis South East Europe d. o.o. Serbia Abaxis, Inc. U

Zoetis Reports Fourth Quarter and Full Year 2022 Results

EXHIBIT 99.1 Zoetis Reports Fourth Quarter and Full Year 2022 Results •For Fourth Quarter 2022, Zoetis Reports Revenue of $2.0 Billion, Growing 4%, and Net Income of $461 Million, or $0.99 per Diluted Share, on a Reported Basis ◦Delivers 9% Operational Growth in Revenue and 27% Operational Growth in Adjusted Net Income for Fourth Quarter 2022 ◦Reports Adjusted Net Income of $539 Million, or Adjust

ZTS / Zoetis Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* Name of issuer: Zoetis Inc. Title of Class of Securities: Common Stock CUSIP Number: 98978V103 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 8, 2023 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of inc

Zoetis Declares Second Quarter 2023 Dividend

EXHIBIT 99.1 Media Contacts: Investor Contacts: Bill Price Steve Frank 1-973-443-2742 (o) 1-973-822-7141 (o) [email protected] [email protected] Kristen Seely Nick Soonthornchai 1-973-443-2777 (o) 1-973-443-2792 (o) [email protected] [email protected] Zoetis Declares Second Quarter 2023 Dividend PARSIPPANY, N.J. – February 8, 2023 –The Board of Directors of Zoetis In

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 7, 2023 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission (I.R.S. Employer of incorpor

Exhibit 10.

Exhibit 10.1 EXECUTION VERSION U.S. $1,000,000,000 REVOLVING CREDIT AGREEMENT dated as of December 21, 2022, among ZOETIS INC., THE LENDERS NAMED HEREIN THE ISSUING BANKS NAMED HEREIN and JPMORGAN CHASE BANK, N.A., as Administrative Agent BANK OF AMERICA, N.A., BARCLAYS BANK PLC, CITIBANK, N.A. and MUFG BANK, LTD., as Syndication Agents BANCO BILBAO VIZCAYA ARGENTARIA, S.A. NEW YORK BRANCH, BANK O

Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 21, 2022 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of in

Exhibit 3.2

Exhibit 3.2 AMENDED AND RESTATED BY-LAWS OF ZOETIS INC. (Amended and Restated as of December 8, 2022) Article I Stockholders? Meetings. 1. Place of Meetings. Meetings of the stockholders shall be held at such time and place within or without the State of Delaware as may be designated by the Board of Directors. 2. Annual Meetings. The annual meeting of the stockholders shall be held on such date an

Zoetis Declares First Quarter 2023 Dividend; Board Approves 15% Payment Increase

EXHIBIT 99.1 Media Contacts: Investor Contacts: Bill Price Steve Frank 1-973-443-2742 (o) 1-973-822-7141 (o) [email protected] [email protected] Kristen Seely Nick Soonthornchai 1-973-443-2777 (o) 1-973-443-2792 (o) [email protected] [email protected] Zoetis Declares First Quarter 2023 Dividend; Board Approves 15% Payment Increase PARSIPPANY, N.J. ? December 8, 2022

Regulation FD Disclosure, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 8, 2022 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of inc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 16, 2022 Zoetis Inc. (Ex

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 16, 2022 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File Number) (IRS Employer

Exhibit 4.1

Exhibit 4.4 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (?DTC?), TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CED

Underwriting Agreement, dated as of November 8, 2022, between the Company and Barclays Capital Inc., BofA Securities, Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC and MUFG Securities Americas Inc., as representatives of the underwriters named in Schedule 1 thereto.

Exhibit 1.1   Zoetis Inc.   $600,000,000 5.400% Senior Notes due 2025 $750,000,000 5.600% Senior Notes due 2032   Underwriting Agreement   November 8, 2022   Barclays Capital Inc. BofA Securities, Inc. Citigroup Global Markets Inc. J.P. Morgan Securities LLC MUFG Securities Americas Inc.   As Representatives of the several Underwriters listed in Schedule 1 hereto   c/o   Barclays Capital Inc. 745

Exhibit 4.1

Exhibit 4.3 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CED

Exhibit 4.8

Exhibit 4.2   ZOETIS INC.   SIXTH SUPPLEMENTAL INDENTURE Dated as of November 16, 2022   5.400% Senior Notes due 2025 5.600% Senior Notes due 2032   (Sixth Supplemental Indenture to the Indenture Dated as of January 28, 2013)   DEUTSCHE BANK TRUST COMPANY AMERICAS, as Trustee       Table of Contents   Page   Article I Definitions 1     Section 1.01 Certain Terms Defined in the Indenture; Additiona

Calculation of Filing Fee Table (Form Type) ZOETIS INC. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities

EXHIBIT 107 Calculation of Filing Fee Table 424(b)(2) (Form Type) ZOETIS INC. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Newly Registered Securities F

$1,350,000,000 Zoetis Inc. $600,000,000 5.400% SENIOR NOTES DUE 2025 $750,000,000 5.600% SENIOR NOTES DUE 2032

TABLE OF CONTENTS ?Filed Pursuant to Rule 424(b)(2) ?Registration No. 333-266591? PROSPECTUS SUPPLEMENT (To Prospectus dated August 5, 2022) $1,350,000,000 Zoetis Inc. $600,000,000 5.400% SENIOR NOTES DUE 2025 $750,000,000 5.600% SENIOR NOTES DUE 2032 ? The 5.400% senior notes due 2025 (the ?2025 notes?) will mature on November 14, 2025?and the 5.600% senior notes due 2032 (the ?2032 notes?) will

Pricing Term Sheet Zoetis Inc. November 8, 2022 $600,000,000 5.400% Senior Notes due 2025 $750,000,000 5.600% Senior Notes due 2032

Issuer Free Writing Prospectus Filed Pursuant to Rule 433 Registration Statement No.

Subject to Completion, Dated November 8, 2022

TABLE OF CONTENTS The information contained in this preliminary prospectus supplement is not complete and may be changed.

Exhibit 10.

ZOETIS INC. 2013 EQUITY AND INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD Zoetis Inc. (the “Company”) has granted to the person named below (the “Participant”), an Award of Restricted Stock Units under Section 8.1 of the Zoetis Inc. 2013 Equity and Incentive Plan, as amended and restated (the “Plan”). This Award is subject to all of the terms, definitions and provisions of this Restricted Stock Unit

Exhibit 10.3

ZOETIS INC. 2013 EQUITY AND INCENTIVE PLAN PERFORMANCE RESTRICTED STOCK UNIT AWARD Zoetis Inc. (the “Company”) has granted to the person named below (the “Participant”), an Award of Performance Restricted Stock Units under Section 9.1 and Article V of the Zoetis Inc. 2013 Equity and Incentive Plan, as amended and restated (the “Plan”). This Award is subject to all of the terms, definitions and pro

Exhibit 10.3

ZOETIS INC. 2013 EQUITY AND INCENTIVE PLAN DIRECTOR RESTRICTED STOCK UNIT AWARD Zoetis Inc. (the “Company”) has granted to the person named below (the “Participant”), an Award of Restricted Stock Units under Section 8.1 of the Zoetis Inc. 2013 Equity and Incentive Plan, as amended and restated (the “Plan”). This Award is subject to all of the terms, definitions and provisions of this Restricted St

Exhibit 10.

ZOETIS INC. 2013 EQUITY AND INCENTIVE PLAN STOCK OPTION AWARD Zoetis Inc. (the “Company”) has granted to the person named below (the “Participant”), a Non-Qualified Stock Option (the “Option”) to purchase the number of Shares of Company common stock (the “Shares”) set forth below at the exercise price per Share set forth below (the “Exercise Price”). This Option is granted under Article VI of the

Exhibit 10.3

ZOETIS INC. 2013 EQUITY AND INCENTIVE PLAN CASH AWARD Zoetis Inc. (the “Company”) has granted to the person named below (the “Participant”), a cash award (“Cash Award”), subject to all of the terms, definitions and provisions of this Cash Award and the Zoetis Inc. 2013 Equity and Incentive Plan, as amended and restated (the “Plan”), which is incorporated herein by reference, as follows: Participan

Zoetis Announces Third Quarter 2022 Results

EXHIBIT 99.1 Zoetis Announces Third Quarter 2022 Results •Reports Revenue of $2.0 Billion, Growing 1%, and Net Income of $529 Million, or $1.13 per Diluted Share, Decreasing 4% and 3%, Respectively, on a Reported Basis for Third Quarter 2022 •Delivers 5% Operational Growth in Revenue and 2% Operational Growth in Adjusted Net Income for Third Quarter 2022 •Reports Adjusted Net Income of $566 Millio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 3, 2022 Zoetis Inc. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 3, 2022 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of inc

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 24, 2022 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of inc

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 13, 2022 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of inc

Zoetis Declares Fourth Quarter 2022 Dividend

Media Contacts: Investor Contacts: Bill Price Steve Frank 1-973-443-2742 (o) 1-973-822-7141 (o) william.

Heidi Chen

Heidi Chen Executive Vice President, General Counsel and Secretary 10 Sylvan Way Parsippany, NJ 07054 E.

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) Zoetis Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, $0.01 par value per sha

As filed with the Securities and Exchange Commission on August 5, 2022

As filed with the Securities and Exchange Commission on August 5, 2022 Registration No.

Filing Fee Exhibit

EXHIBIT 107 Calculation of Filing Fee Table FORM S-3 (Form Type) ZOETIS INC. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forwar

As filed with the Securities and Exchange Commission on August 5, 2022

As filed with the Securities and Exchange Commission on August 5, 2022 Registration No.

Statement of Eligibility and Qualification on Form T-1 under the Trust Indenture Act of 1939, as amended

EX-25.1 4 tm2222066d2ex25-1.htm EXHIBIT 25.1 Exhibit 25.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) DEUTSCHE BANK TRUST COMPANY AMERICAS (formerly BANKERS TRUST

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 00

Zoetis Announces Second Quarter 2022 Results

EXHIBIT 99.1 Zoetis Announces Second Quarter 2022 Results ?Reports Revenue of $2.1 Billion, Growing 5%, and Net Income of $529 Million, or $1.12 per Diluted Share, Increasing 3% and 5%, Respectively, on a Reported Basis for Second Quarter 2022 ?Delivers 8% Operational Growth in Revenue and 9% Operational Growth in Adjusted Net Income for Second Quarter 2022 ?Reports Adjusted Net Income of $567 Mil

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 4, 2022 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incor

Exhibit 10.

Exhibit 10.1 ZOETIS INC. 2013 EQUITY AND INCENTIVE PLAN AMENDED AND RESTATED AS OF MAY 19, 2022 ARTICLE I PURPOSE The purposes of the Zoetis Inc. 2013 Equity and Incentive Plan, as amended and restated as of May 19, 2022, the ?Plan?) are to provide long-term incentives to those individuals with significant responsibility for the success and growth of the Company and its Affiliates, to align the in

Zoetis Appoints Vanessa Broadhurst to its Board of Directors Johnson & Johnson executive brings valuable business leadership, consumer insights and direct-to-consumer advertising experience to Zoetis Board

Exhibit 99.1 FOR IMMEDIATE RELEASE: July 25, 2022 Media Contacts: Investor Contact: Bill Price Steve Frank 1-973-443-2742 (o) 1-973-822-7141 (o) [email protected] [email protected] Kristen Seely 1-973-443-2777 (o) [email protected] Zoetis Appoints Vanessa Broadhurst to its Board of Directors Johnson & Johnson executive brings valuable business leadership, consumer insights and d

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 25, 2022 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incorp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K (Mark One) ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No: 001-35797 A. Full title of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 (State or Other Jurisdiction (Commission File Number)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 (State or Other Jurisdiction (Commission File Number) of Incorporation) 10 Sylvan Way Parsippany, NJ 07054 (Address of principal executive office) (Zip code) Heidi C. Chen Executive Vice President, Genera

Conflict Minerals Report for Zoetis Inc. For the Year Ended December 31, 2021

Exhibit 1.01 Conflict Minerals Report for Zoetis Inc. For the Year Ended December 31, 2021 Introduction This Conflict Minerals Report (the ?Report?) has been prepared by Zoetis Inc. (?Zoetis,? the ?Company,? ?we,? ?us,? or ?our?) as provided for in Rule 13p-1 under the Securities Exchange Act of 1934, as amended, and Form SD (collectively, the ?Conflict Minerals Rule?), for the reporting period fr

Exhibit 3.1

Exhibit 3.1 RESTATED CERTIFICATE OF INCORPORATION OF ZOETIS INC. Zoetis Inc. (the ?Corporation?), a corporation organized and existing under the General Corporation Law of the State of Delaware (the ?GCL?), does hereby certify as follows: 1. The name of the Corporation is Zoetis Inc. The Corporation was originally incorporated under the name Zoetis Inc., pursuant to the original Certificate of Inc

Exhibit 3.2

Exhibit 3.2 AMENDED AND RESTATED BY-LAWS OF ZOETIS INC. (Amended and Restated as of May 19, 2022) Article I Stockholders? Meetings. 1. Place of Meetings. Meetings of the stockholders shall be held at such time and place within or without the State of Delaware as may be designated by the Board of Directors. 2. Annual Meetings. The annual meeting of the stockholders shall be held on such date and at

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 19, 2022 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incorpo

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 19, 2022 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incorpo

Zoetis Declares Third Quarter 2022 Dividend

Exhibit 99.1 FOR IMMEDIATE RELEASE: May 19, 2022 Media Contacts: Investor Contact: Bill Price Steve Frank 1-973-443-2742 (o) 1-973-822-7141 (o) [email protected] [email protected] Kristen Seely 1-973-443-2777 (o) [email protected] Zoetis Declares Third Quarter 2022 Dividend PARSIPPANY, N.J. ? May 19, 2022 ?The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend

Zoetis Announces First Quarter 2022 Results

EXHIBIT 99.1 Zoetis Announces First Quarter 2022 Results ?Reports Revenue of $2.0 Billion, Growing 6%, and Net Income of $595 Million, or $1.26 per Diluted Share, Increasing 6% and 8%, Respectively, on a Reported Basis for First Quarter 2022 ?Delivers 9% Operational Growth in Revenue and 8% Operational Growth in Adjusted Net Income for First Quarter 2022 ?Reports Adjusted Net Income of $625 Millio

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 5, 2022 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incorpor

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 19, 2022 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incor

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin

definitive proxy statement for the 2022

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ? SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ????) ? Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? ? Confidential, for Use of the Commission Only (as permitted

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.     )

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ? SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ????) ? Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? ? Confidential, for Use of the Commission Only (as permitted

Exhibit 21.1

Exhibit 21.1 SUBSIDIARIES OF THE COMPANY The following is a list of subsidiaries of the company as of December 31, 2021, omitting some subsidiaries which, considered in the aggregate, would not constitute a significant subsidiary. SUBSIDIARY NAME JURISDICTION OF INCORPORATION / FORMATION Abaxis Asia Limited Hong Kong Abaxis Europe GmbH Germany Abaxis South East Europe d. o.o. Serbia Abaxis UK Limi

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 15, 2022 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of in

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35

Exhibit 4.1

Exhibit 4.17 DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Zoetis Inc. (?Zoetis,? the ?Company,? ?we,? ?us? and ?our?) had one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the ?Exchange Act?): our common stock, par value $0.01 per share. Description of Common Stock The follo

Zoetis Reports Fourth Quarter and Full Year 2021 Results

EXHIBIT 99.1 Zoetis Reports Fourth Quarter and Full Year 2021 Results ?For Fourth Quarter 2021, Zoetis Reports Revenue of $2.0 Billion, Growing 9%, and Net Income of $414 Million, or $0.87 per Diluted Share, on a Reported Basis ?Reports Adjusted Net Income of $474 Million, or Adjusted Diluted EPS of $1.00, for Fourth Quarter 2021 ?Delivers 9% Operational Growth in Revenue and 5% Operational Growth

Exhibit 4.1

THIS CERTIFIES THAT is the owner of CUSIP DATED COUNTERSIGNED AND REGISTERED: COMPUTERSHARE TRUST COMPANY, N.

ZTS / Zoetis Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7)* Name of issuer: Zoetis Inc. Title of Class of Securities: Common Stock CUSIP Number: 98978V103 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ??Rule 13

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 8, 2022 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of inc

Zoetis Declares Second Quarter 2022 Dividend

Exhibit 99.1 FOR IMMEDIATE RELEASE: Feb. 8, 2022 Media Contacts: Investor Contacts: Bill Price Steve Frank 1-973-443-2742 (o) 1-973-822-7141 (o) [email protected] [email protected] Kristen Seely Keith Gaub 1-973-443-2777 (o) 1-973-822-7154 (o) [email protected] [email protected] Zoetis Declares Second Quarter 2022 Dividend PARSIPPANY, N.J. ? February 8, 2022 ?The Board of Di

Zoetis Announces Authorization of $3.5 Billion Share Repurchase Program Company Also Declares First Quarter 2022 Dividend; Board Approves 30% Payment Increase

Exhibit 99.1 FOR IMMEDIATE RELEASE: Dec. 7, 2021 Media Contacts: Investor Contacts: Bill Price Steve Frank 1-973-443-2742 (o) 1-973-822-7141 (o) [email protected] [email protected] Kristen Seely Keith Gaub 1-973-443-2777 (o) 1-973-822-7154 (o) [email protected] [email protected] Zoetis Announces Authorization of $3.5 Billion Share Repurchase Program Company Also Declares Fir

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 7, 2021 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of inc

Zoetis Announces Third Quarter 2021 Results

EXHIBIT 99.1 Zoetis Announces Third Quarter 2021 Results ?Reports Revenue of $2.0 Billion, Growing 11%, and Net Income of $552 Million, or $1.16 per Diluted Share, Increasing 15% and 16%, Respectively, on a Reported Basis for Third Quarter 2021 ?Reports Adjusted Net Income of $597 Million, or Adjusted Diluted EPS of $1.25, for Third Quarter 2021 ?Delivers 10% Operational Growth in Revenue and 10%

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 4, 2021 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of inc

Exhibit 15

Exhibit 15 ACCOUNTANTS? ACKNOWLEDGEMENT November 4, 2021 Zoetis Inc. Parsippany, New Jersey Re: Registration Statements (Nos. 333-186367, 333-189573, 333-200073, and 333-226481) on Form S-8 With respect to the subject registration statements, we acknowledge our awareness of the use therein of our report dated November 4, 2021 related to our review of interim financial information. Pursuant to Rule

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 18, 2021 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction of incorporation) (Commission File Numbe

Zoetis Announces Appointment of Robert J. Polzer, PhD, as President of Research & Development for World Leader in Animal Health Dr. Catherine Knupp Culminates Remarkable Career of Advancing Animal Care with Breakthrough New Products and Continuous In

Exhibit 99.1 FOR IMMEDIATE RELEASE Media Contacts: Investor Contacts: Bill Price Steve Frank 1-973-443-2742 (o) 1-973-822-7141 (o) [email protected] [email protected] Kristen Seely Keith Gaub 1-973-443-2777 (o) 1-973-822-7154 (o) [email protected] [email protected] Zoetis Announces Appointment of Robert J. Polzer, PhD, as President of Research & Development for World Leader

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 14, 2021 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of inc

Zoetis Declares Fourth Quarter 2021 Dividend

Exhibit 99.1 FOR IMMEDIATE RELEASE: October 14, 2021 Media Contacts: Investor Contacts: Bill Price Steve Frank 1-973-443-2742 (o) 1-973-822-7141 (o) [email protected] [email protected] Kristen Seely Keith Gaub 1-973-443-2777 (o) 1-973-822-7154 (o) [email protected] [email protected] Zoetis Declares Fourth Quarter 2021 Dividend PARSIPPANY, N.J. ? Oct. 14, 2021 - The Board of

Exhibit 15

Exhibit 15 ACCOUNTANTS? ACKNOWLEDGEMENT August 5, 2021 Zoetis Inc. Parsippany, New Jersey Re: Registration Statements (Nos. 333-186367, 333-189573, 333-200073, and 333-226481) on Form S-8 With respect to the subject registration statements, we acknowledge our awareness of the use therein of our report dated August 5, 2021 related to our review of interim financial information. Pursuant to Rule 436

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 00

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 5, 2021 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incor

Zoetis Announces Second Quarter 2021 Results

EXHIBIT 99.1 Zoetis Announces Second Quarter 2021 Results ?Reports Revenue of $1.9 Billion, Growing 26%, and Net Income of $512 Million, or $1.07 per Diluted Share, Increasing 36% and 35%, Respectively, on a Reported Basis for Second Quarter 2021 ?Reports Adjusted Net Income of $566 Million, or Adjusted Diluted EPS of $1.19, for Second Quarter 2021 ?Delivers 22% Operational Growth in Revenue and 2

Exhibit 10.30

Exhibit 10.1 Zoetis Supplemental Savings Plan Amendment No.2 This Amendment No. 2 (the ?Amendment?) to the Zoetis Supplemental Savings Plan, as amended and restated effective September 15, 2014 and as further amended effective December 21, 2020 (the ?Plan?), is dated and effective as of May 15, 2021. 1. Section 2.20 of the Plan is amended in its entirety to read as follows: 2.20 Key Employee. The

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILAR PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILAR PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or TRANSITION REPORT PURSUANT TO SECTIO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or Other Jurisdiction (Commission Fi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or Other Jurisdiction (Commission File Number) (IRS Employer of Incorporation) Identification No.) 10 Sylvan Way Parsippany, NJ 07054 (Address of principal executive office) Heidi C. Che

Conflict Minerals Report for Zoetis Inc. For the Year Ended December 31, 2020

EX-1.01 2 zoetis2020conflictminerals.htm EX-1.01 Exhibit 1.01 Conflict Minerals Report for Zoetis Inc. For the Year Ended December 31, 2020 Introduction This Conflict Minerals Report (the “Report”) has been prepared by Zoetis Inc. (“Zoetis,” the “Company,” “we,” “us,” or “our”) as provided for in Rule 13p-1 under the Securities Exchange Act of 1934, as amended, and Form SD (collectively, the “Conf

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 20, 2021 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incorpo

Zoetis Announces Results of Its Annual Meeting of Shareholders; Board Declares Third Quarter 2021 Dividend

Exhibit 99.1 FOR IMMEDIATE RELEASE: May 20, 2021 Media Contacts: Investor Contacts: Bill Price Steve Frank 1-973-443-2742 (o) 1-973-822-7141 (o) [email protected] [email protected] Kristen Seely Keith Gaub 1-973-443-2777 (o) 1-973-822-7154 (o) [email protected] [email protected] Zoetis Announces Results of Its Annual Meeting of Shareholders; Board Declares Third Quarter 2021

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 20, 2021 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incorpo

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2021 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission (I.R.S. Employer of incorporation

Zoetis Announces Appointment of Glenn David as Group President and Wetteny Joseph as Executive Vice President and Chief Financial Officer

Exhibit 99.1 FOR IMMEDIATE RELEASE Media Contacts: Investor Contacts: Bill Price Steve Frank 1-973-443-2742 (o) 1-973-822-7141 (o) [email protected] [email protected] Kristen Seely Keith Gaub 1-973-443-2777 (o) 1-973-822-7154 (o) [email protected] [email protected] Zoetis Announces Appointment of Glenn David as Group President and Wetteny Joseph as Executive Vice President a

Exhibit 10.29

Exhibit 10.1 Zoetis Inc. 10 Sylvan Way Parsippany, NJ 07054 May 5, 2021 Mr. Wetteny Joseph Dear Wetteny, On behalf of Zoetis, Kristin Peck and I are delighted to extend to you an offer to join Zoetis in the position of Executive Vice President, Chief Financial Officer and Head of Business Development. All who interviewed you were impressed by your background and experience and we look forward to y

Zoetis Announces First Quarter 2021 Results

EXHIBIT 99.1 Zoetis Announces First Quarter 2021 Results ?Reports Revenue of $1.9 Billion, Growing 22%, and Net Income of $559 Million, or $1.17 per Diluted Share, Increasing 32% and 33%, Respectively, on a Reported Basis for First Quarter 2021 ?Reports Adjusted Net Income of $603 Million, or Adjusted Diluted EPS of $1.26, for First Quarter 2021 ?Delivers 21% Operational Growth in Revenue and 34%

Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 6, 2021 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incorpor

Exhibit 15

Exhibit 15 ACCOUNTANTS? ACKNOWLEDGEMENT May 6, 2021 Zoetis Inc. Parsippany, New Jersey Re: Registration Statements (Nos. 333-186367, 333-189573, 333-200073, and 333-226481) on Form S-8 and (No. 333-226450) on Form S-3 With respect to the subject registration statements, we acknowledge our awareness of the use therein of our report dated May 6, 2021 related to our review of consolidated interim fin

- DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ? SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ????) ? Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2

- DEF 14A

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ? SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ????) ? Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? ? Confidential, for Use of the Commission Only (as permitted

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 23, 2021 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incor

Zoetis Reports Fourth Quarter and Full Year 2020 Results

EXHIBIT 99.1 Zoetis Reports Fourth Quarter and Full Year 2020 Results •For Fourth Quarter 2020, Zoetis Reports Revenue of $1.8 Billion, Growing 8%, and Net Income of $359 Million, or $0.75 per Diluted Share, on a Reported Basis ◦Reports Adjusted Net Income of $438 Million, or Adjusted Diluted EPS of $0.91, for Fourth Quarter 2020 ◦Delivers 9% Operational Growth in Revenue and 3% Operational Growth

Exhibit 10.24

Exhibit 10.24 ZOETIS SUPPLEMENTAL SAVINGS PLAN AMENDMENT This Amendment (this ?Amendment?) to the Zoetis Supplemental Savings Plan (the ?Plan?) is dated and effective as of December 21, 2020. 1. Amendment. Section 6.7 of the Plan is hereby amended and restated as follows: 6.7 Permitted Delays. Notwithstanding the foregoing, to the extent permitted by applicable laws and regulations, including Sect

Annual Report - 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35

Exhibit 10.26

Exhibit 10.26 ZOETIS EQUITY DEFERRAL PLAN AMENDMENT NO. 1 This Amendment No. 1 (this ?Amendment?) to the Zoetis Equity Deferral Plan (the ?Plan?) is dated and effective as of December 21, 2020. 1. Amendment. Section 5.8 of the Plan is hereby amended and restated as follows: 5.8 Permitted Delays. Notwithstanding the foregoing, to the extent permitted by applicable laws and regulations, including Se

Exhibit 21.1

Exhibit 21.1 SUBSIDIARIES OF THE COMPANY The following is a list of subsidiaries of the company as of December 31, 2020, omitting some subsidiaries which, considered in the aggregate, would not constitute a significant subsidiary. SUBSIDIARY NAME JURISDICTION OF INCORPORATION / FORMATION Abaxis Asia Holding Limited Hong Kong Abaxis Europe GmbH Germany Abaxis South East Europe d. o.o. Serbia Abaxis

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 16, 2021 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of in

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 6)*

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 6)* Name of issuer: Zoetis Inc. Title of Class of Securities: Common Stock CUSIP Number: 98978V103 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13

Zoetis Declares Second Quarter 2021 Dividend

Exhibit 99.1 FOR IMMEDIATE RELEASE: Feb. 10, 2021 Media Contacts: Investor Contacts: Bill Price Steve Frank 1-973-443-2742 (o) 1-973-822-7141 (o) [email protected] [email protected] Kristen Seely Keith Gaub 1-973-443-2777 (o) 1-973-822-7154 (o) [email protected] [email protected] Zoetis Declares Second Quarter 2021 Dividend PARSIPPANY, N.J. – Feb. 10, 2021 – The Board of Dir

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 10, 2021 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of in

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 8, 2020 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of inc

Zoetis Declares First Quarter 2021 Dividend; Board Approves 25% Payment Increase

Exhibit 99.2 FOR IMMEDIATE RELEASE: Dec. 9, 2020 Media Contacts: Investor Contacts: Bill Price Steve Frank 1-973-443-2742 (o) 1-973-822-7141 (o) [email protected] [email protected] Kristen Seely Keith Gaub 1-973-443-2777 (o) 1-973-822-7154 (o) [email protected] [email protected] Zoetis Declares First Quarter 2021 Dividend; Board Approves 25% Payment Increase PARSIPPANY, N.J.

Zoetis Appoints Tonie Leatherberry to its Board of Directors Former Deloitte executive and technology leader brings valuable digital and data experience to Zoetis Board

Exhibit 99.1 FOR IMMEDIATE RELEASE Dec. 8, 2020 Media Contacts: Investor Contacts: Bill Price Steve Frank 1-973-443-2742 (o) 1-973-822-7141 (o) [email protected] [email protected] Kristen Seely Keith Gaub 1-973-443-2777 (o) 1-973-822-7154 (o) [email protected] [email protected] Zoetis Appoints Tonie Leatherberry to its Board of Directors Former Deloitte executive and technol

Exhibit 15

Exhibit 15 ACCOUNTANTS’ ACKNOWLEDGEMENT November 5, 2020 Zoetis Inc. Parsippany, New Jersey Re: Registration Statements (Nos. 333-186367, 333-189573, 333-200073, and 333-226481) on Form S-8 and (No. 333-226450) on Form S-3 With respect to the subject registration statements, we acknowledge our awareness of the use therein of our report dated November 5, 2020 related to our review of consolidated i

Zoetis Announces Third Quarter 2020 Results

EXHIBIT 99.1 Zoetis Announces Third Quarter 2020 Results •Reports Revenue of $1.8 Billion, Growing 13%, and Net Income of $479 Million, or $1.00 per Diluted Share, Both Increasing 11% on a Reported Basis, for Third Quarter 2020 •Reports Adjusted Net Income of $524 Million, or Adjusted Diluted EPS of $1.10 for Third Quarter 2020 •Delivers 15% Operational Growth in Revenue and 20% Operational Growth

Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe

Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 5, 2020 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of inc

Regulation FD Disclosure, Financial Statements and Exhibits - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 7, 2020 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of inco

Zoetis Declares Fourth Quarter 2020 Dividend

Exhibit 99.1 FOR IMMEDIATE RELEASE: Oct. 7, 2020 Media Contacts: Investor Contacts: Bill Price Steve Frank 1-973-443-2742 (o) 1-973-822-7141 (o) [email protected] [email protected] Kristen Seely Keith Gaub 1-973-443-2777 (o) 1-973-822-7154 (o) [email protected] [email protected] Zoetis Declares Fourth Quarter 2020 Dividend PARSIPPANY, N.J. – Oct. 7, 2020 - The Board of Direc

Other Events - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 10, 2020 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of i

Zoetis Announces Second Quarter 2020 Results

EXHIBIT 99.1 Zoetis Announces Second Quarter 2020 Results •Reports Flat Revenue of $1.5 Billion, and Net Income of $377 Million, or $0.79 per Diluted Share, Increasing 2% and 3%, Respectively, on a Reported Basis for Second Quarter 2020 •Reports Adjusted Net Income of $427 Million, or Adjusted Diluted EPS of $0.89 for Second Quarter 2020 •Delivers 4% Operational Growth in Revenue and 4% Operationa

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 6, 2020 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incor

Exhibit 15

Exhibit 15 ACCOUNTANTS’ ACKNOWLEDGEMENT August 6, 2020 Zoetis Inc. Parsippany, New Jersey Re: Registration Statements (Nos. 333-186367, 333-189573, 333-200073, and 333-226481) on Form S-8 and (No. 333-226450) on Form S-3 With respect to the subject registration statements, we acknowledge our awareness of the use therein of our report dated August 6, 2020 related to our review of consolidated inter

Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 00

- 11-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILAR PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or ¨ TRANSITION REPORT PURSUANT TO SE

- SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or Other Jurisdiction (Commission File Number) (IRS Employer of Incorporation) Identification No.) 10 Sylvan Way Parsippany, NJ 07054 (Address of principal executive office) Heidi C. Che

Conflict Minerals Report for Zoetis Inc. For the Year Ended December 31, 2019

Exhibit 1.01 Conflict Minerals Report for Zoetis Inc. For the Year Ended December 31, 2019 Introduction This Conflict Minerals Report (the “Report”) has been prepared by Zoetis Inc. (“Zoetis,” the “Company,” “we,” “us,” or “our”) as provided for in Rule 13p-1 under the Securities Exchange Act of 1934, as amended, and Form SD (collectively, the “Conflict Minerals Rule”), for the reporting period fr

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 20, 2020 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incorpo

Zoetis Announces Results of Its Annual Meeting of Shareholders; Board Declares Third Quarter 2020 Dividend

Exhibit 99.1 FOR IMMEDIATE RELEASE: May 20, 2020 Media Contacts: Investor Contacts: Christina Lood Steve Frank 1-973-822-7249 (o) 1-973-822-7141 (o) [email protected] [email protected] Kristen Seely Marissa Patel 1-973-443-2777 (o) 1-973-443-2996 (o) [email protected] [email protected] Zoetis Announces Results of Its Annual Meeting of Shareholders; Board Declares Third Q

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 20, 2020 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incorpo

Exhibit 4.7

EX-4.2 Exhibit 4.2 ZOETIS INC. FIFTH SUPPLEMENTAL INDENTURE Dated as of May 12, 2020 2.000% Senior Notes due 2030 3.000% Senior Notes due 2050 (Fifth Supplemental Indenture to the Indenture Dated as of January 28, 2013) DEUTSCHE BANK TRUST COMPANY AMERICAS, as Trustee TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 1 Section 1.01 Certain Terms Defined in the Indenture; Additional Terms 1 Section 1.02

Underwriting Agreement, dated as of May 7, 2020, between the Company and Barclays Capital Inc., BofA Securities, Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC and MUFG Securities Americas Inc., as representatives of the underwriters named in Schedule 1 thereto.

EX-1.1 Exhibit 1.1 Zoetis Inc. $750,000,000 2.000% Senior Notes due 2030 $500,000,000 3.000% Senior Notes due 2050 Underwriting Agreement May 7, 2020 Barclays Capital Inc. BofA Securities, Inc. Citigroup Global Markets Inc. J.P. Morgan Securities LLC MUFG Securities Americas Inc. As Representatives of the several Underwriters listed in Schedule 1 hereto c/o Barclays Capital Inc. 745 Seventh Avenue